Back
Johnson & Johnson Vs. Halozyme Therapeutics, Inc. Sector Stock Comparison
Buy
62
JNJ
Johnson & Johnson
Last Price:
$207.36
Seasonality Move:
1.27%
Buy
62
HALO
Halozyme Therapeutics, Inc.
Last Price:
$70.30
Seasonality Move:
5.49%
Buy
62
Johnson & Johnson (JNJ)
is a Buy
Is Johnson & Johnson a Buy, Sell or Hold?
-
The current Johnson & Johnson [JNJ] share price is $207.35. The Score for JNJ is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
JNJ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Halozyme Therapeutics, Inc. [HALO] share price is $67.30. The Score for HALO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $207.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JNJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics, Inc.'s stock price today?
-
The Halozyme Therapeutics, Inc. share price today is $67.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight selling pressure.
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.77 | Buy |
| Relative Strength Index (14 RSI): | 55.79 | Buy |
| Chaikin Money Flow: | 6206159 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.75 - 209.89) | Buy |
| Bollinger Bands (100): | (178.66 - 202.76) | Buy |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 51.52 | Buy |
| Chaikin Money Flow: | -382406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.09 - 69.53) | Buy |
| Bollinger Bands (100): | (65.02 - 73.68) | Sell |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.16 | Buy |
| 20-day SMA: | 206.99 | Buy |
| 50-day SMA: | 200.21 | Buy |
| 200-day SMA: | 174.13 | Buy |
| 8-day EMA: | 207.33 | Buy |
| 20-day EMA: | 206.45 | Buy |
| 50-day EMA: | 200.84 | Buy |
| 200-day EMA: | 180.57 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.14 | Sell |
| 20-day SMA: | 65.32 | Buy |
| 50-day SMA: | 67.27 | Buy |
| 200-day SMA: | 63.63 | Buy |
| 8-day EMA: | 67.56 | Sell |
| 20-day EMA: | 66.93 | Buy |
| 50-day EMA: | 67.27 | Buy |
| 200-day EMA: | 63.99 | Buy |
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.86 per share.
Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.88 per share, and an increase next year of $1.43 per share.
Johnson & Johnson Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||